Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial

Publication | Closed Access

DOI

Citations

References

2021

Year

Yao‐Chun Hsu, Chi-Yi Chen, I‐Wei Chang, Chi‐Yang Chang, Chun‐Ying Wu, Teng‐Yu Lee, Ming‐Shiang Wu, Ming‐Jong Bair, Jyh-Jou Chen, Chieh‐Chang Chen,

The Lancet Infectious Diseases

HepatologyViral HepatitisMedicineRandomised TrialHepatitis BHepatitisAntiviral TherapyChronic Hepatitis BPharmacotherapyLiver DiseaseTreatment-naive Taiwanese PatientsPharmacology